Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Hybrid coronary revascularization can potentially resolve that predicament by combining the two treatments, stenting some blockages and bypassing others. By bringing together the best of the catheterization lab and the operating room, we can protect your heart and avoid open surgery.
WHAT WE OFFER YOU FOR HYBRID CORONARY REVASCULARIZATION
Access to a specialized treatment not widely available. We perform hybrid revascularization without opening your chest or stopping your heart. When appropriate, we use robotic assistance during bypass.
Minimally invasive option for people who previously did not have one. A minimally invasive approach means a shorter hospital stay, less pain immediately after treatment, and a faster recovery.
Highly specialized expertise with a lead surgeon who specializes in the hybrid approach and has completed extensive training. Our procedure builds on years of experience and innovation with CABG and stenting.
What is Hybrid Coronary Revascularization?
Conditions Treated Using Hybrid Coronary Revascularization
Like coronary artery bypass graft surgery (CABG) or coronary angioplasty, hybrid coronary revascularization is used to open blocked arteries. Patients with blocked arteries have obstructive coronary artery disease, which is treatable.
The Stanford Interventional Cardiology program is a leader in diagnosing and treating coronary artery disease, offering minimally invasive procedures and treatments. Our interventional team typically sees new patients within two weeks.
The Stanford Valvular Heart Disease Clinic brings together different disciplines for a team approach to care. Our team specializes in the latest minimally invasive treatments.